These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9411321)

  • 1. [Role of aldosterone in potassium secretion in chronic renal failure associated with hypertension (transtubular potassium gradient)].
    Radó J; Tóth A; Haris A
    Orv Hetil; 1997 Oct; 138(40):2517-20. PubMed ID: 9411321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperkalemia unresponsive to massive doses of aldosterone in a patient with renal tubular acidosis.
    Radó JP; Szende L; Szücs L
    Endokrinologie; 1976; 68(2):183-8. PubMed ID: 1009902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potassium-lowering effect of albuterol for hyperkalemia in renal failure.
    Montoliu J; Lens XM; Revert L
    Arch Intern Med; 1987 Apr; 147(4):713-7. PubMed ID: 3827459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between creatinine clearance and transtubular potassium concentration gradient in old people and chronic renal disease patients.
    Musso C; Liakopoulos V; Stefanidis I; De Miguel R; Imperiali N; Algranati L
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):551-5. PubMed ID: 17951942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothesis: a simple algorithm to distinguish between hypoaldosteronism and renal aldosterone resistance in patients with persistent hyperkalemia.
    Adam WR
    Nephrology (Carlton); 2008 Dec; 13(6):459-64. PubMed ID: 18518934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potassium-aldosterone response in dogs with chronic renal insufficiency.
    Bourgoignie JJ; Gavellas G; Van Putten V; Berl T
    Miner Electrolyte Metab; 1985; 11(3):150-4. PubMed ID: 4010647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correction of hyperkalemia with intravenous salbutamol in children with chronic renal insufficiency].
    Arias-Reyes JA; Matos-Martínez M; Velásquez-Jones L; Dubey-Ortega LA
    Bol Med Hosp Infant Mex; 1989 Sep; 46(9):603-6. PubMed ID: 2604875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium and renal failure.
    Kunis CL; Charney AN
    Compr Ther; 1981 Mar; 7(3):29-33. PubMed ID: 7237977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of calcium channel blockers on potassium homeostasis.
    Freed MI; Rastegar A; Bia MJ
    Yale J Biol Med; 1991; 64(2):177-86. PubMed ID: 1750228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hyperkalemia in the chronic renal failure: is it always the aldosterone the responsible?].
    Martin R; Arrizurieta de Muchnik E
    Medicina (B Aires); 1982; 42(4):445-7. PubMed ID: 15171028
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients.
    Kaisar MO; Wiggins KJ; Sturtevant JM; Hawley CM; Campbell SB; Isbel NM; Mudge DW; Bofinger A; Petrie JJ; Johnson DW
    Am J Kidney Dis; 2006 May; 47(5):809-14. PubMed ID: 16632019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudohypoaldosteronism: case report and discussion of the syndrome.
    Throckmorton DC; Bia MJ
    Yale J Biol Med; 1991; 64(3):247-54. PubMed ID: 1788991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperkalemia in salt-wasting nephropathy. Study of the mechanism.
    Popovtzer MM; Katz FH; Pinggera WF; Robinette J; Halgrimson CG; Butkus DE
    Arch Intern Med; 1973 Aug; 132(2):203-8. PubMed ID: 4719548
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches.
    Ngugi NN; McLigeyo SO; Kayima JK
    East Afr Med J; 1997 Aug; 74(8):503-9. PubMed ID: 9487416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperkalemia unresponsive to massive doses of aldosterone and renal tubular acidosis in a patient with chronic interstitial nephritis: clinical and experimental studies.
    Radó JP; Szende L; Szucs L
    J Med; 1976; 7(6):481-510. PubMed ID: 188961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertension, hyperpotassemia and normal glomerular filtration (Gordon's syndrome): a case report].
    Fortini A; Nenci G; Laureano R; Cappelletti C
    G Ital Cardiol; 1996 Jan; 26(1):51-6. PubMed ID: 8682260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antihypertensives on plasma potassium in end stage renal disease: a retrospective study.
    Tripathi M; Kaushik S; Gaur A; Kher V
    J Indian Med Assoc; 1997 Oct; 95(10):543-5, 547. PubMed ID: 9567598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.